10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001558370-22-017789`
Period End Date	20220930
Filing Date	20221114
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	bpth-20220930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 42 Cash Flow Statement 39 Stockholders Equity 23

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$23.77M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$13.65M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$2.35M	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$523.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.14M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.84M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$26.14M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$18.14M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	7.16M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	7.16M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.10M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	7.16M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	7.16M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$939.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$874.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$225.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$181.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$221.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$203.00K	USD	Point-in-time
Total Assets	`Assets`	$26.57M	USD	Point-in-time
Total Assets	`Assets`	$18.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$106.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.05M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$770.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$105.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$82.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$958.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$141.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$153.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.11M	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.34M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 7,160 and 7,160 shares issued and outstanding, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 7,160 and 7,160 shares issued and outstanding, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$103.11M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$103.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-87.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-77.66M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$16.20M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$29.35M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$25.46M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$29.75M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$19.52M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$15.07M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$26.57M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$18.54M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$6.30M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$981.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.35M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.00M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.19M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.09M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.32M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.61M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$6.33M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$9.91M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$3.55M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.07M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.33M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-3.55M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-9.91M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.07M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$13.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$11.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$13.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$11.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.54M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.32M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.90M	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.29	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.49	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.96	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.38	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.38	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.96	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.29	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.49	USD	1 Quarter
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.04M	shares	1 Quarter
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	6.58M	shares	3 Qtrs
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.16M	shares	1 Quarter
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.16M	shares	3 Qtrs
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.16M	shares	1 Quarter
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.04M	shares	1 Quarter
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.16M	shares	3 Qtrs
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	6.58M	shares	3 Qtrs

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.54M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.32M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.90M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$642.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$591.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$67.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$63.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$56.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$65.00K	USD	3 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$840.00K	USD	3 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$1.82M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$591.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$297.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.22M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$74.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$70.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.12M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.10M	USD	3 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.00K	USD	3 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-21.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-47.00K	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$15.85M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$12.20M	USD	Point-in-time
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$4.16M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.01M	USD	3 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-10.12M	USD	3 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.85M	USD	3 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.65M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.60M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.77M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.76M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.65M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.60M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.77M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.76M	USD	Point-in-time
Right of use asset recognized in exchange for lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$85.00K	USD	3 Qtrs

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$16.20M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$29.35M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$25.46M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$29.75M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$19.52M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$15.07M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$15.85M	USD	3 Qtrs
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$1.40M	USD	1 Quarter
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$4.16M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$212.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$642.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$591.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$262.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.54M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.32M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.90M	USD	3 Qtrs
Ending Balance	`StockholdersEquity`	$16.20M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$29.35M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$25.46M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$29.75M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$19.52M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$15.07M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.